Mark Borgaonkar

2.1k total citations
48 papers, 1.0k citations indexed

About

Mark Borgaonkar is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark Borgaonkar has authored 48 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Surgery, 18 papers in Oncology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark Borgaonkar's work include Colorectal Cancer Screening and Detection (17 papers), Gastric Cancer Management and Outcomes (9 papers) and Inflammatory Bowel Disease (8 papers). Mark Borgaonkar is often cited by papers focused on Colorectal Cancer Screening and Detection (17 papers), Gastric Cancer Management and Outcomes (9 papers) and Inflammatory Bowel Disease (8 papers). Mark Borgaonkar collaborates with scholars based in Canada, United States and United Kingdom. Mark Borgaonkar's co-authors include John K. Marshall, Marroon Thabane, Cindy James, John Fardy, Donald MacIntosh, Stephen M. Collins, E. Jan Irvine, Grigorios I. Leontiadis, Frances Tse and Elizabeth F. Churchill and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Gut.

In The Last Decade

Mark Borgaonkar

44 papers receiving 959 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Borgaonkar Canada 14 366 291 247 200 187 48 1.0k
Omar Kherad Switzerland 16 499 1.4× 102 0.4× 425 1.7× 117 0.6× 240 1.3× 74 990
Mike Thomson United Kingdom 24 1.4k 3.7× 723 2.5× 180 0.7× 113 0.6× 162 0.9× 124 2.0k
Patrick F. van Rheenen Netherlands 24 599 1.6× 156 0.5× 720 2.9× 930 4.7× 72 0.4× 71 1.9k
Adam Mezoff United States 20 417 1.1× 187 0.6× 405 1.6× 543 2.7× 26 0.1× 45 1.3k
Stéphane Nahon France 21 645 1.8× 329 1.1× 885 3.6× 977 4.9× 143 0.8× 91 1.7k
Farahnaz Joukar Iran 22 413 1.1× 181 0.6× 586 2.4× 54 0.3× 172 0.9× 156 1.6k
M. Guilera Spain 20 320 0.9× 143 0.5× 688 2.8× 348 1.7× 72 0.4× 44 1.3k
Conor G. Loftus United States 12 460 1.3× 184 0.6× 489 2.0× 486 2.4× 61 0.3× 42 1.1k
Sharmeel K. Wasan United States 15 200 0.5× 123 0.4× 433 1.8× 463 2.3× 46 0.2× 49 1.2k
Elizabeth Weinshel United States 19 595 1.6× 203 0.7× 276 1.1× 17 0.1× 219 1.2× 55 1.1k

Countries citing papers authored by Mark Borgaonkar

Since Specialization
Citations

This map shows the geographic impact of Mark Borgaonkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Borgaonkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Borgaonkar more than expected).

Fields of papers citing papers by Mark Borgaonkar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Borgaonkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Borgaonkar. The network helps show where Mark Borgaonkar may publish in the future.

Co-authorship network of co-authors of Mark Borgaonkar

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Borgaonkar. A scholar is included among the top collaborators of Mark Borgaonkar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Borgaonkar. Mark Borgaonkar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bernstein, Çharles N., Remo Panaccione, Zoann Nugent, et al.. (2024). Crohn’s Disease Phenotypes and Associations With Comorbidities, Surgery Risk, Medications and Nonmedication Approaches: The MAGIC in IMAGINE Study. Inflammatory Bowel Diseases. 31(1). 113–122. 1 indexed citations
2.
Fairbridge, Nicholas A., et al.. (2023). An estimation of the endoscopist's musculoskeletal injury risk for right and left lateral decubitus positions during colonoscopy: a field-based ergonomic study. BMC Musculoskeletal Disorders. 24(1). 475–475. 2 indexed citations
3.
Borgaonkar, Mark, et al.. (2023). Assessing Frequency and Appropriateness of Proton Pump Inhibitor Deprescription in Patients Requiring Endoscopic Therapy for Esophageal Strictures. Journal of the Canadian Association of Gastroenterology. 6(6). 229–233.
4.
5.
Borgaonkar, Mark, et al.. (2022). Optimizing cecal views during colonoscopy using patient position change. Surgical Endoscopy. 36(9). 6522–6526. 4 indexed citations
6.
Ellsmere, James, et al.. (2021). Colonoscopy skills improvement training improves patient comfort during colonoscopy. Surgical Endoscopy. 36(6). 4588–4592. 3 indexed citations
7.
Ménard, Charles, Kevin Waschke, Frances Tse, et al.. (2020). COVID-19: Framework for the Resumption of Endoscopic Activities From the Canadian Association of Gastroenterology. Journal of the Canadian Association of Gastroenterology. 3(5). 243–245. 4 indexed citations
8.
Pace, David, et al.. (2019). Effect of an educational intervention on colonoscopy quality outcomes. Surgical Endoscopy. 34(11). 5142–5147. 12 indexed citations
9.
Jones, Jennifer, et al.. (2017). BioAdvance Patient Support Program Survey: Positive Perception of Intravenous Infusions of Infliximab.. PubMed. 26(2). 41–48. 2 indexed citations
10.
Pace, David, Mark Borgaonkar, Brad R. Evans, et al.. (2016). Annual colonoscopy volume and maintenance of competency for surgeons. Surgical Endoscopy. 31(6). 2630–2635. 8 indexed citations
11.
Pace, David, Mark Borgaonkar, Brad R. Evans, et al.. (2015). Does the hands-on, technical training of residents in colonoscopy affect quality outcomes?. Surgical Endoscopy. 30(4). 1352–1355. 4 indexed citations
12.
Borgaonkar, Mark, Lawrence Hookey, Roger Hollingworth, et al.. (2012). Indicators of Safety Compromise in Gastrointestinal Endoscopy. SHILAP Revista de lepidopterología. 26(2). 71–78. 16 indexed citations
13.
Marshall, John K., Marroon Thabane, Mark Borgaonkar, & Cindy James. (2007). Postinfectious Irritable Bowel Syndrome After a Food-Borne Outbreak of Acute Gastroenteritis Attributed to a Viral Pathogen. Clinical Gastroenterology and Hepatology. 5(4). 457–460. 167 indexed citations
14.
Samarasena, Jason & Mark Borgaonkar. (2007). Development of Hepatocellular Carcinoma in a Patient with Crohn’s Disease Treated with Azathioprine. Digestive Diseases and Sciences. 52(10). 2748–2750. 11 indexed citations
15.
Borgaonkar, Mark, et al.. (2006). The Incidence of Irritable Bowel Syndrome Among Community Subjects With Previous Acute Enteric Infection. Digestive Diseases and Sciences. 51(5). 1026–1032. 59 indexed citations
16.
Samarasena, Jason, et al.. (2006). Individuals Homozygous for the H63D Mutation Have Significantly Elevated Iron Indexes. Digestive Diseases and Sciences. 51(4). 803–807. 18 indexed citations
17.
Borgaonkar, Mark, et al.. (2000). Quality of life measurement in gastrointestinal and liver disorders. Gut. 47(3). 444–454. 173 indexed citations
18.
Borgaonkar, Mark, et al.. (2000). CASE REPORT: Acute on Chronic Intestinal Pseudoobstruction Responds to Neostigmine. Digestive Diseases and Sciences. 45(8). 1644–1647. 11 indexed citations
19.
Borgaonkar, Mark, Donald MacIntosh, & John Fardy. (2000). A meta-analysis of antimycobacterial therapy for Crohn's disease. The American Journal of Gastroenterology. 95(3). 725–729. 72 indexed citations
20.
Borgaonkar, Mark, et al.. (1999). Anti-tuberculous therapy for maintenance of remission in Crohn's disease. Cochrane Database of Systematic Reviews. CD000299–CD000299. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Omar Kherad Breakdown of academic impact, for papers by Mike Thomson Breakdown of academic impact, for papers by Patrick F. van Rheenen Breakdown of academic impact, for papers by Adam Mezoff Breakdown of academic impact, for papers by Stéphane Nahon Breakdown of academic impact, for papers by Farahnaz Joukar Breakdown of academic impact, for papers by M. Guilera Breakdown of academic impact, for papers by Conor G. Loftus Breakdown of academic impact, for papers by Sharmeel K. Wasan Breakdown of academic impact, for papers by Elizabeth Weinshel
Rankless by CCL
2026